| scholarly article | Q13442814 |
| P50 | author | Nicholas John White | Q21166848 |
| Brian J Angus | Q42305778 | ||
| P2093 | author name string | Yupin Suputtamongkol | |
| Itaporn Thaiaporn | |||
| Kenechanh Chanthapadith | |||
| P2860 | cites work | Assessment of the pharmacodynamic properties of antimalarial drugs in vivo | Q24670346 |
| Neurotoxicity of artemisinin analogs in vitro | Q33756907 | ||
| Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria | Q33979153 | ||
| Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine | Q35121790 | ||
| A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. | Q35802096 | ||
| Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria | Q38925749 | ||
| The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria | Q38945844 | ||
| Averting a malaria disaster | Q39118502 | ||
| Studies of the neurotoxicity of oral artemisinin derivatives in mice. | Q39308519 | ||
| Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice | Q39308526 | ||
| Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study | Q39309831 | ||
| A simple method for assessing quinine pre-treatment in acute malaria | Q39462284 | ||
| Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria | Q39517554 | ||
| Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria | Q40678753 | ||
| Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria | Q40680523 | ||
| A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria. | Q47863256 | ||
| Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination | Q48009282 | ||
| Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria | Q48012248 | ||
| The epidemiology of malaria in a Karen population on the western border of Thailand | Q48030577 | ||
| Neurotoxicity in animals due to arteether and artemether | Q48112147 | ||
| Simultaneous determination of artesunic acid and dihydroartemisinin in blood plasma by high-performance liquid chromatography for application in clinical pharmacological studies | Q73425256 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| Plasmodium falciparum | Q311383 | ||
| artesunate | Q707939 | ||
| P304 | page(s) | 778-782 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Oral artesunate dose-response relationship in acute falciparum malaria | |
| P478 | volume | 46 |
| Q34071772 | A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial). |
| Q28551461 | Ameliorative Effects of Curcumin on Artesunate-Induced Subchronic Toxicity in Testis of Swiss Albino Male Mice |
| Q34106578 | Ancient Chinese methods are remarkably effective for the preparation of artemisinin-rich extracts of Qing Hao with potent antimalarial activity. |
| Q36717631 | Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. |
| Q37278622 | Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy |
| Q22061852 | Artemisinin Resistance in Plasmodium falciparum Malaria |
| Q35521094 | Artemisinins |
| Q43228042 | Artesunate dosing in severe falciparum malaria |
| Q34509744 | Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea |
| Q34437996 | CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide |
| Q93198126 | Chemical Synthesis, Efficacy, and Safety of Antimalarial Hybrid Drug Comprising of Sarcosine and Aniline Pharmacophores as Scaffolds |
| Q36338542 | Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997-2007. |
| Q36669256 | Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria |
| Q36584916 | Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria |
| Q36076111 | How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance? |
| Q28552379 | Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial |
| Q34120984 | Intravenous artesunate for the treatment of severe malaria |
| Q58812735 | Mitigative effects of Moringa oleifera against liver injury induced by artesunate-amodiaquine antimalarial combination in wistar rats |
| Q22061804 | New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus Mefloquine |
| Q28472247 | Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria |
| Q34020238 | Pharmacogenetics of antimalarial drugs: effect on metabolism and transport |
| Q26830528 | Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization |
| Q47967717 | Pharmacokinetics and pharmacodynamics of arterolane maleate following multiple oral doses in adult patients with P. falciparum malaria |
| Q34669043 | Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC. |
| Q36364184 | Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia |
| Q45973898 | Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria. |
| Q48026045 | Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria |
| Q48022076 | Poor response to artesunate treatment in two patients with severe malaria on the Thai-Myanmar border |
| Q35669950 | Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea |
| Q36959519 | Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations |
| Q28595897 | Reply to Meshnick and Hastings et al |
| Q35827084 | Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin |
| Q55252884 | Synthesis and molecular modelling studies of pyrimidinones and pyrrolo[3,4-d]-pyrimidinodiones as new antiplasmodial compounds. |
| Q43595043 | The Importance of Scientific Debate in the Identification, Containment, and Control of Artemisinin Resistance |
| Q37928680 | The pharmacogenetics of antimalaria artemisinin combination therapy |
| Q37841602 | The pharmacokinetic evaluation of artemisinin drugs for the treatment of malaria in paediatric populations |
| Q39301025 | The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria |
| Q37272811 | Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers |
Search more.